Efficacy and safety of repeated perioperative doses of recombinant factor VIIa in liver transplantation

Liver Transplantation

Volumn 11, Issue 8, 2005, Pages 973-979

  Lodge, J Peter A ^a   Jonas, Sven ^b   Jones, Robert M ^c   Olausson, Michael ^d   Mir Pallardo, José ^e   Soefelt, Soeren ^f   Garcia Valdecasas, Juan Carlos ^g   McAlister, Vivian ^h   Mirza, Darius F ⁱ   Malagó, Massimo ^j   Nadalin, Silvio ^j   Garden, James ^j   Heaton, Nigel ^j   Ortiz de Urbina, Jorge ^j   Gastaca, Mikel ^j   Ericzon, Bo Göran ^j   Watts, Andrew ^j   Chung, Stephen ^j   Levy, Gary ^j   Metrakos, Peter ^j   Marty, Jean ^j   Lagneau, Frank ^j   more..

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c AUSTIN HOSPITAL   (Australia)

^d SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^e HOSPITAL UNIVERSITARIO LA FE   (Spain)

^f NOVO NORDISK A S   (Denmark)

^g University Hospital   (Spain)

^h LONDON HEALTH SCIENCES CENTRE   (Canada)

ⁱ QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^j NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ADULT; ARTICLE; BLOOD DISEASE; CLINICAL TRIAL; CONGENITAL MALFORMATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; ERYTHROCYTE TRANSFUSION; FAMILIAL DISEASE; FEMALE; GASTROINTESTINAL DISEASE; GENETIC DISORDER; HEART DISEASE; HEPATOBILIARY DISEASE; HOSPITALIZATION; HUMAN; IMMUNOPATHOLOGY; INFECTION; INFESTATION; INJURY; INTOXICATION; KIDNEY DISEASE; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LYMPHATIC SYSTEM DISEASE; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM DISEASE; METABOLIC DISORDER; MULTICENTER STUDY; NEUROLOGIC DISEASE; NUTRITIONAL DISORDER; OPERATION DURATION; PERIOPERATIVE PERIOD; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PROTHROMBIN TIME; RANDOMIZED CONTROLLED TRIAL; REOPERATION; RESPIRATORY TRACT DISEASE; THORAX DISEASE; THROMBOEMBOLISM; URINARY TRACT DISEASE; VASCULAR DISEASE;

ADULT; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; ERYTHROCYTE TRANSFUSION; FACTOR VII; FEMALE; HUMANS; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE CARE; PREMEDICATION; PROTHROMBIN TIME; RECOMBINANT PROTEINS; TREATMENT OUTCOME;

EID: 23744440522     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.20470     Document Type: Article

References (21)

1. Qian YB, Cheng GH, Huang JF. Multivariate regression analysis on early mortality after orthotopic liver transplantation. World J Gastroenterol 2002;8:128-130.
2. Palomo Sanchez JC, Jimenez C, Moreno Gonzalez E, Garcia I, Palma F, Loinaz C, Gonzalez Ghamorro A. Effects of intraoperative blood transfusion on postoperative complications and survival after orthotopic liver transplantation. Hepatogastroenterology 1998;45:1026-1033.
3. Schroeder RA, Johnson LB, Plotkin JS, Kuo PC, Klein AS. Total blood transfusion and mortality after orthotopic liver transplantation [Letter]. Anesthesiology 1999;91:329-330.
4. Ramos E, Dalmau A, Sabate A, Lama C, Llado L, Figueras J, Jaurrieta E. Intraoperative red blood cell transfusion in liver transplantation: influence on patient outcome, prediction of requirements, and measures to reduce them. Liver Transpl 2003; 9:1320-1327.
5. Cacciarelli TV, Keeffe EB, Moore DH, Burns W, Busque S, Concepcion W, et al. Effect of intraoperative blood transfusion on patient outcome in hepatic transplantation. Arch Surg 1999; 134:25-29.
6. Spahn DR, Casutt M. Eliminating blood transfusions. Anesthesiology 2000;93:242-255.
7. Hoffman M, Monroe DM III. A cell-based model of hemostasis. Thromb Haemost 2001;85:958-965.
8. Monroe DM, Hoffman M, Oliver JA, Roberts HR. Platelet activity of high-dose factor VIIa is independent of tissue factor. Br J Haematol 1997;99:542-547.
9. Monroe DM, Hoffman M, Oliver JA, Roberts HR. A possible mechanism of action of activated factor VII independent of tissue factor. Blood Coagul Fibrinolysis 1998;9(Suppl 1):S15-S20.
10. Hendriks HGD, Meijer K, de Wolf JThM, Klompmaker IJ, Porte RJ, de Kam PJ, et al. Reduced transfusion requirements by recombinant factor VIIa in orthotopic liver transplantation: a pilot study. Transplantation 2001;71:402-405.
11. Meijer K, Hendriks HG, De Wolf JT, Klompmaker IJ, Lisman T, Hagenaars AA, et al. Recombinant factor VIIa in orthotopic liver transplantation: influence on parameters of coagulation and fibrinolysis. Blood Coagul Fibrinolysis 2003;14:169-174.
12. Planinsic RM, van der Meer J, Testa G, Grande L, Candela A, Porte RJ, et al. Safety and efficacy of a single bolus administration of recombinant factor VIIa in liver transplantation due to chronic liver disease. Liver Transpl 2005;11:895-900.
13. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973;60:646-649.
14. Hollander M, Wolfe DA. Nonparametric statistical methods. New York: John Wiley & Sons; 1973.
15. Adam R, McMaster P, O'Grady JG, Castaing D, Klempnauer JL, Jamieson N, et al; European Liver Transplant Association. Evolution of liver transplantation in Europe: report of the European Liver Transplant Registry. Liver Transpl 2003;9:1231-1243.
16. Rossaint R, Riou B, Boffard K, Kluger Y, Rizoli S, Warren B, et al. A randomized, placebo-controlled, double-blind study to investigate the efficacy and safety of rFVIIa as adjunctive therapy for control of bleeding in patients with severe blunt trauma: a re-analysis following the exclusion of early (<48 hours) deaths. Paper presented at the 25th Annual Meeting of Intensive Care and Emergency Medicine, Brussels, Belgium, March 21-25, 2005.
17. Laine E, Steadman R, Calhoun L, Blackall D, Levin P, Braunfeld M, et al. Comparison of RBCs and FFP with whole blood during liver transplant surgery. Transfusion 2003;43:322-327.
18. Nielsen HJ. Detrimental effects of perioperative blood transfusion. Br J Surg 1995;82:582-587.
19. Landers DR, Hill GE, Wong KC, Fox IJ. Blood transfusion-induced immunomodulation. Anesth Analg 1996;82:187-204.
20. Lodge JPA, Jonas S, Oussoultzoglou E, Malago M, Jayr C, Cherqui D, et al. Recombinant coagulation factor VIIa (NovoSeven®) in major liver resection: a randomized, placebo-controlled, double-blind clinical trial. Anesthesiology 2005; 102: 269-275.
21. Bosch J, Thabut D, Bendtsen F, D'Amico G, Albillos A, Gonzalez Abraldes J, et al. Recombinant factor VIIa for upper gastrointestinal bleeding in patients with cirrhosis: a randomized, double-blind trial. European Study Group on rFVIIa in UGI Haemorrhage. Gastroenterology 2004;127:1123-1130.